通过粉样β毛孔的病理性流入扰乱了突触功能
Temitope Adeoye1, Ghanim Ullah1
1Department of Physics, University of South Florida, Tampa, FL 33620, USA.
Cell calcium
|October 5, 2025
概括
阿尔茨海默病 (AD) 涉及粉样β (Aβ) 寡合体破坏 (Ca2+) 恒温. 这项研究模拟了Aβ毛孔如何改变突触传输,揭示了神经递质释放和AD中ER功能障碍与ER功能障碍相互作用的复杂影响.
科学领域:
- 神经科学是一个神经科学.
- 计算生物学 计算生物学
- 细胞生物学 细胞生物学
背景情况:
- 阿尔茨海默病 (AD) 与突触功能障碍和粉样β (Aβ) 寡合体有关,这些寡合体通过膜孔破坏 (Ca2+) 恒温.
- 这些Aβ孔对突触传播的确切影响以及它们与家族性AD (FAD) 相关的内质网膜 (ER) 功能障碍的相互作用尚未完全理解.
研究的目的:
- 为了建模Aβ毛孔如何影响突触前Ca2+动态,表细胞和神经递质释放.
- 为了研究Aβ毛孔和FAD相关的ER功能障碍对突触功能的联合影响.
主要方法:
- 扩展了先前存在的 Ca2+ 前突触动态的计算模型.
- 模拟了Aβ毛孔与不同活动模式对神经递质释放的影响.
- 分析了Aβ毛孔与ER Ca2+失调之间的相互作用.
主要成果:
- Aβ毛孔显著改变神经递质释放时间和强度.
- 持续的毛孔活动会导致突触过活;短暂的强烈活动会导致持久的低活化.
- Aβ 孔和 ER 功能障碍协同相互作用,产生复杂的 Ca2+ 干扰并改变释放模式,特别是异步释放.
结论:
- Aβ 孔从根本上破坏突触功能,其影响取决于其活动模式.
- Aβ毛孔和ER功能障碍之间的相互作用会产生一种病理单元,加剧突触失效.
- 阿尔茨海默氏症早期的突触功能障碍可能源于时间释放协调问题,而不是仅仅是Ca2+失调.
相关概念视频
Amyloid Fibrils
11.6K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
11.6K
Amyloid Fibrils
6.3K
6.3K
Ligand-Gated Ion Channel Receptor: Gating Mechanism
3.8K
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
3.8K
Chemical Synapses
11.3K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
11.3K
Chemical Synapses
4.3K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
4.3K
Alzheimer's Disease: Overview
1.6K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.6K


